Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris Wins Landmark First US Interchangeability Designation For Semglee
Allows Pharmacy Substitution For Insulin Glargine Biosimilar Rival To Lantus
Jul 29 2021
•
By
David Wallace
Viatris’ Semglee will now be able to be substituted for Lantus • Source: Alamy
More from Biosimilars
More from Products